This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Estee Lauder (EL) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Adverse impacts of coronavirus-induced temporary store closures and sluggishness in travel retail are likely to get reflected in Estee Lauder's (EL) first-quarter fiscal 2021 performance.
Altria (MO) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Altria's (MO) third-quarter 2020 results are likely to reflect gains from pricing and strength in oral tobacco products. However, cigarette volumes have been soft for a while.
Here's All You Should Note Before Kellogg's (K) Q3 Earnings
by Zacks Equity Research
Kellogg's (K) third-quarter results are likely to reflect strength in the retail business due to increased pandemic-led demand. However, soft away-from-home food demand and high costs are concerns.
Estee Lauder (EL) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Estee Lauder (EL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
All You Should Know Before Church & Dwight (CHD) Q3 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) third-quarter 2020 results are likely to reflect increased demand for household cleaning products amid the pandemic, though escalated costs are a concern.
NUS vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
NUS vs. EL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Zacks Market Edge Highlights: Amazon, Alibaba, Estee Lauder, RealReal and RH
by Zacks Equity Research
Zacks Market Edge Highlights: Amazon, Alibaba, Estee Lauder, RealReal and RH
Luxury Retail: Who's Winning During the Pandemic?
by Patrick Anderson
Innovation usually comes when a company is pushed to the brink. Will the luxury retailers come out of the coronavirus even stronger than before/
Coronavirus-Led Woes Hurt Coty (COTY), E-commerce Looks Solid
by Zacks Equity Research
Weakness in the Consumer Beauty segment along with currency headwinds are a concern for Coty (COTY). Nevertheless, its strategic partnerships and online business bode well.
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
by Zacks Equity Research
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
4 Cosmetics Stocks to Buff Up Your Portfolio Amid Industry Challenges
by Zacks Equity Research
The Zacks Cosmetics industry is facing COVID-19 woes like disturbed travel retail, low traffic and soft makeup demand. Rising demand for personal care products however bodes well for HELE, NUS, IPAR and ELF, which are focused on adapting to the changing market trends.
Top Analyst Reports for Facebook, Walmart & Morgan Stanley
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Walmart (WMT) and Morgan Stanley (MS).
Weekly Jobless Claims Increase Again
by Zacks Equity Research
Weekly Jobless Claims Increase Again.
Weekly Jobless Data Worsens, Q2 Earnings Mixed, Futures Dip
by Zacks Equity Research
Weekly jobless claims data surpasses one million mark again for the week ended Aug 15.
Estee Lauder's (EL) Q4 Loss Wider Than Estimates, Sales Down
by Zacks Equity Research
Estee Lauder's (EL) fourth-quarter fiscal 2020 sales decline due to coronavirus-induced retail store closures. The company launches a two-year plan called Post-COVID Business Acceleration Program.
Estee Lauder (EL) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of -178.95% and -1.32%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Estee Lauder (EL)
by Zacks Equity Research
Estee Lauder (EL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The 5 Hottest Earnings Charts This Week
by Tracey Ryniec
Who says only the FAANG stocks are breaking out?
Here's How Estee Lauder (EL) Looks Ahead of Q4 Earnings
by Zacks Equity Research
Adverse impacts of coronavirus-induced temporary store closures and sluggishness in travel retail are likely to get reflected in Estee Lauder's (EL) fourth-quarter fiscal 2020 results.
Analysts Estimate Estee Lauder (EL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Estee Lauder (EL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NUS vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Here's How Post Holdings (POST) Looks Ahead of Q3 Earnings
by Zacks Equity Research
Impacts of higher costs as well as lower demand in foodservice business are likely to get reflected in Post Holdings' (POST) third-quarter fiscal 2020 performance.
What's in the Cards for Medifast (MED) This Earnings Season?
by Zacks Equity Research
Strength in OPTAVIA brand is likely to get reflected in Medifast's (MED) second-quarter 2020 performance. However, rising SG&A expenses is a concern.
Things to Know Before Celsius Holdings (CELH) Q2 Earnings
by Zacks Equity Research
Celsius Holdings' (CELH) second-quarter results are likely to have benefited from strong brands and its solid network of retailers and distributors. However, rising costs are concerning.